News
智通财经APP获悉，阿里拉姆制药(ALNY.US)今天宣布，治疗高血压的在研RNAi疗法Zilebesiran在名为KARDIA-1的2期临床试验中达到了主要终点，在接受治疗后3个 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible resultsResults that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback